A vaccine that is used to reverse Leder congenital amaurosis (LCA), an incurable type of blindness that affects over 100,000 Americans, may prove effective as a coronavirus vaccine. The vaccine AAACOVID leverages a unique strategy, adeno-associated viral vector (AAV), to eradicate a virus before it can establish a foothold in the body. Administered through a single injection, it works by exposing genetic sequences of the SARS-CoV-2 Spike antigen to the body’s immune system. The body then quickly learns to recognize and defend against it. AAACOVID’s delivery system is what makes it unique, and it has a distinct advantage in the race for a coronavirus vaccine because it’s proven safe, effective, and quickly adaptable for use in a wide variety of indications over the past 25 years. It is also the only vaccine in development that’s already approved by the FDA for clinical use. Learn more at https://bit.ly/36qXSvh
